• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

New “Evolution Engine” Can Mutate Target Genes 100,000 Times Faster Than Normal

August 12, 2025 by Deborah Bloomfield

The evolution of proteins isn’t just something that happens out in the wild. It can happen in the lab, too, and brings with it the possibility of developing new and improved proteins that can be used in all sorts of useful ways. Trouble is, that’s also a massive slog – until now.

The rest of this article is behind a paywall. Please sign in or subscribe to access the full content.

A team from the Department of Chemistry and Skaggs Institute for Chemical Biology at the Scripps Research Institute have developed a so-called “evolution engine”, which can continuously introduce mutations into living bacterial cells at a rate 100,000 times higher than it would naturally acquire them.

“This is like giving evolution a fast-forward button,” said co-senior author Pete Schultz, the President and CEO of Scripps Research, in a statement. “You can now evolve proteins continuously and precisely inside cells without damaging the cell’s genome or requiring labor-intensive steps.”

The “engine” is called T7-ORACLE and works by introducing an artificial DNA replication system into E. coli. Yep, you read that right; not all E. coli gives you an iffy belly – it’s also widely used to produce proteins, as it grows easily and rapidly.

This second, separate replication system doesn’t target E. coli’s main, chromosomal DNA, leaving the host cell unaffected. Instead, it targets small, circular pieces of DNA called plasmids, which are often introduced into bacteria for the purpose of producing large amounts of proteins.

Schematic of the T7-ORACLE system. The genome is maintained by the non-mutagenic host replisome (gray), while an orthogonal T7 replisome (red) maintains only a dedicated plasmid (OR) at 100,000-fold elevated mutation rate.

The T7-ORACLE system.

Image credit: Scripps Research

According to the researchers, it’s a simple system to set up. “The main thing that sets this apart is how easy it is to implement,” said co-senior author Christian Diercks, an assistant professor of chemistry at Scripps Research. “There’s no specialized equipment or expertise required. If you already work with E. coli, you can probably use this system with minimal adjustments.”

The team tested the system out with a gene encoding a protein that gives bacteria antibiotic resistance, and gradually exposed E. coli cells to increasingly high doses of antibiotics. The results were impressively rapid; it took less than a week for a protein to evolve that could handle a dose up to 5,000 times higher than the first.

“This system represents a major advance in continuous evolution,” said Diercks. “Instead of one round of evolution per week, you get a round each time the cell divides – so it really accelerates the process.”

It’s hoped that the T7-ORACLE system could be at its most useful in medicine, helping to speed up the process of finding new and improved therapeutic proteins for all kinds of conditions, including cancers and neurodegenerative diseases.

“What’s exciting is that it’s not limited to one disease or one kind of protein,” Diercks explained. “Because the system is customizable, you can drop in any gene and evolve it toward whatever function you need.”

“[W]e can now evolve virtually any protein, like cancer drug targets and therapeutic enzymes, in days instead of months.”

The study is published in Science.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Skype alumni head to court in a battle over Starship Technologies and Wire
  2. Fed’s Powell: ‘Frustrating’ that supply chain kinks aren’t getting better
  3. Five Thousand Years Ago, Africa Had A Major Civilization We Forgot
  4. Rubbing A Banana Peel On Your Face Is Not Some Big Skincare Secret – It’s Just Pointless

Source Link: New “Evolution Engine” Can Mutate Target Genes 100,000 Times Faster Than Normal

Filed Under: News

Primary Sidebar

  • The Bizarre 1997 Experiment That Made A Frog Levitate
  • There’s A Very Good Reason Why October 1582 On Your Phone Is Missing 10 Days
  • Skynet-1A: Military Spacecraft Launched 56 Years Ago Has Been Moved By Persons Unknown
  • There’s A Simple Solution To Helping Avoid Erectile Dysfunction (But You’re Not Going To Like It)
  • Interstellar Object 3I/ATLAS May Be 10 Billion Years Old, This Rare Spider Is Half-Female, Half-Male Split Down The Middle, And Much More This Week
  • Why Do Trains Not Have Seatbelts? It’s Probably Not What You Think
  • World’s Driest Hot Desert Just Burst Into A Rare And Fleeting Desert Bloom
  • Theoretical Dark Matter Infernos Could Melt The Earth’s Core, Turning It Liquid
  • North America’s Largest Mammal Once Numbered 60 Million – Then Humans Nearly Drove It To Extinction
  • North America’s Largest Ever Land Animal Was A 21-Meter-Long Titan
  • A Two-Headed Fossil, 50/50 Spider, And World-First Butt Drag
  • Interstellar Comet 3I/ATLAS Is Losing Buckets Of Water Every Second – And It’s Got Cyanide
  • “A Historic Shift”: Renewables Generated More Power Than Coal Globally For First Time
  • The World’s Oldest Known Snake In Captivity Became A Mom At 62 – No Dad Required
  • Biggest Ocean Current On Earth Is Set To Shift, Spelling Huge Changes For Ecosystems
  • Why Are The Continents All Bunched Up On One Side Of The Planet?
  • Why Can’t We Reach Absolute Zero?
  • “We Were Onto Something”: Highest Resolution Radio Arc Shows The Lowest Mass Dark Object Yet
  • How Headsets Made For Cyclists Are Giving Hearing And Hope To Kids With Glue Ear
  • It Was Thought Only One Mammal On Earth Had Iridescent Fur – Turns Out There’s More
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version